Impact of Vendor Systems on Ambulatory Medication Safety
BWHCERT5E
1 other identifier
observational
20
1 country
2
Brief Summary
Our objective is to determine the effects of electronic prescribing on medication safety including medication errors, near misses and preventable adverse drug events in the ambulatory setting. Study design will be a longitudinal evaluation of errors early after implementation and after sustained use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2008
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
October 3, 2008
CompletedFirst Posted
Study publicly available on registry
October 16, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedFebruary 28, 2012
February 1, 2012
2.8 years
October 3, 2008
February 27, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
prescribing error
1 year
Secondary Outcomes (2)
near misses
1 year
preventable adverse drug events
1 year
Study Arms (2)
1
Providers adopting electronic prescribing in New York City, New York
2
Providers adopting electronic prescribing in the Taconic region of New York
Interventions
Implementation of a commercially available electronic prescribing system with clinical decision support
Eligibility Criteria
Our study will take place in 2 NYS communities. We will select 2 communities in order to assemble a study population with the following characteristics: use of at least 2 different vendor-based systems, different implementation times (with some communities being early adopters and others experienced users), and inclusion of urban underserved and federally defined rural areas. We will select the following 2 communities/organizations: the community health centers implementing electronic prescribing with the New York City Department of Health (NYC DOH) and the Taconic Health Information Network and Community (THINC) in the Hudson Valley of New York. Both communities have expressed their interest in participating in this study.
You may qualify if:
- \>=0.75 FTE providers
You may not qualify if:
- \<0.75 FTE providers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Taconic IPA
Fishkill, New York, 12524, United States
New York City Department of Health and Mental Hygiene
New York, New York, 10038, United States
Related Publications (1)
Abramson EL, Pfoh ER, Barron Y, Quaresimo J, Kaushal R. The effects of electronic prescribing by community-based providers on ambulatory medication safety. Jt Comm J Qual Patient Saf. 2013 Dec;39(12):545-52. doi: 10.1016/s1553-7250(13)39070-9.
PMID: 24416945DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rainu Kaushal, MD, MPH
Weill Medical College of Cornell University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 3, 2008
First Posted
October 16, 2008
Study Start
September 1, 2008
Primary Completion
July 1, 2011
Study Completion
October 1, 2011
Last Updated
February 28, 2012
Record last verified: 2012-02